EXPERIENCE IN THE USE OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN TREATMENT OF PERENNIAL ALLERGIC RHINITIS AND CONCOMITANT ATOPIC DERMATITIS

Abstract

Allergen-specific immunotherapy (ASIT) is currently recognized as the only treatment that can affect all links in the pathological process of allergic diseases. Airway hyperresponsiveness is significantly reduced in case of allergy respiratory manifestations, which reduces symptoms severity and the need for drugs. The article describes a clinical observation of the ASIT positive effect in persistent atopic dermatitis (AtD) with concomitant respiratory allergy and complete atopic triad development. The authors propose to consider ASIT as a preventive therapy for bronchial asthma and allergic rhinitis if patient has AtD manifestations with confirmed sensitization to aeroallergens.